Find HDV and Determine Its Status in Turkey SITU(HD)VATION

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Adults (Age≥18)

• Being HBsAg positive for at least six months

• Being a citizen of the Republic of Türkiye

Locations
Other Locations
Turkey
Guven Hospital
RECRUITING
Ankara
Dicle University, Faculty of Medicine
RECRUITING
Diyarbakır
Contact Information
Primary
Yaşar Bayındır, MD
yasar.bayindir@guven.com.tr
00905323659909
Backup
Mustafa Kemal Çelen, MD
00905336207022
Time Frame
Start Date: 2024-03-11
Estimated Completion Date: 2025-03-01
Participants
Target number of participants: 20000
Treatments
Family Physicians
1\. 250 Family Physicians
HDV Screening
2\. 20,000 HBsAg positive patients
Sponsors
Collaborators: SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY, Gilead Sciences
Leads: Yaşar Bayındır, MD

This content was sourced from clinicaltrials.gov